These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 16866649)

  • 41. Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections.
    Bassetti M; Repetto E; Righi E; Boni S; Diverio M; Molinari MP; Mussap M; Artioli S; Ansaldi F; Durando P; Orengo G; Bobbio Pallavicini F; Viscoli C
    J Antimicrob Chemother; 2008 Feb; 61(2):417-20. PubMed ID: 18174197
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU.
    Kallel H; Bahloul M; Hergafi L; Akrout M; Ketata W; Chelly H; Hamida CB; Rekik N; Hammami A; Bouaziz M
    Int J Antimicrob Agents; 2006 Oct; 28(4):366-9. PubMed ID: 16971093
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Nosocomial infections with multiresistant bacteria--not only staphylococci].
    Petersson J; Giske CG; Aufwerber E; Jörbeck H
    Lakartidningen; 2006 Aug 30-Sep 5; 103(35):2478-81. PubMed ID: 17002165
    [No Abstract]   [Full Text] [Related]  

  • 44. Possible role of integrase gene polymerase chain reaction as an epidemiological marker: study of multidrug-resistant Acinetobacter baumannii isolated from nosocomial infections.
    Gaur A; Prakash P; Anupurba S; Mohapatra TM
    Int J Antimicrob Agents; 2007 Apr; 29(4):446-50. PubMed ID: 17270402
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Infection control practices need ingenuous processes beyond prescribed guidelines.
    Agrawal C; Mehta A
    Indian J Pathol Microbiol; 2011; 54(2):419-20. PubMed ID: 21623118
    [No Abstract]   [Full Text] [Related]  

  • 46. Acinetobacter baumannii: a universal threat to public health?
    Giamarellou H; Antoniadou A; Kanellakopoulou K
    Int J Antimicrob Agents; 2008 Aug; 32(2):106-19. PubMed ID: 18571905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiresistant acinetobacter in the UK: how big a threat?
    Coelho J; Woodford N; Turton J; Livermore DM
    J Hosp Infect; 2004 Nov; 58(3):167-9. PubMed ID: 15501329
    [No Abstract]   [Full Text] [Related]  

  • 48. An outbreak caused by multidrug-resistant OXA-58-positive Acinetobacter baumannii in an intensive care unit in Italy.
    Moro M; Nizzero P; Biancardi A; Baldan R; Scarpellini P; Curti C; Cichero P; Ossi C; Mancini N; Colombo S; Marazzi M; Mazzuconi R; Cirillo DM
    J Hosp Infect; 2008 Jan; 68(1):97-9. PubMed ID: 18063199
    [No Abstract]   [Full Text] [Related]  

  • 49. Acinetobacter infection.
    Munoz-Price LS; Weinstein RA
    N Engl J Med; 2008 Mar; 358(12):1271-81. PubMed ID: 18354105
    [No Abstract]   [Full Text] [Related]  

  • 50. [New findings on the genus Acinetobacter].
    Hostacká A
    Epidemiol Mikrobiol Imunol; 2000 Nov; 49(4):174-7. PubMed ID: 11188766
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii.
    Tseng YC; Wang JT; Wu FL; Chen YC; Chie WC; Chang SC
    Diagn Microbiol Infect Dis; 2007 Oct; 59(2):181-90. PubMed ID: 17662564
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Acinetobacter baumannii, the nosocomial pathogen par excellence].
    Nordmann P
    Pathol Biol (Paris); 2004 Jul; 52(6):301-3. PubMed ID: 15261370
    [No Abstract]   [Full Text] [Related]  

  • 53. Nosocomial multidrug-resistant Acinetobacter baumannii in the neonatal intensive care unit in Gaza City, Palestine.
    Al Jarousha AM; El Jadba AH; Al Afifi AS; El Qouqa IA
    Int J Infect Dis; 2009 Sep; 13(5):623-8. PubMed ID: 19144555
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa.
    Bonomo RA; Szabo D
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S49-56. PubMed ID: 16894515
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Acinetobacter calcoaceticus, a potential pathogen with an increasing role in pathology].
    Georgescu C; Neguţ M; Marinescu L; Călin C; Boboc F; Georgescu-Brăila M; Florescu DP; Trifan G
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1984; 29(4):333-9. PubMed ID: 6522946
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmacodynamics of antibiotics to treat multidrug-resistant Gram-positive hospital infections.
    Pea F; Viale P
    Expert Rev Anti Infect Ther; 2007 Apr; 5(2):255-70. PubMed ID: 17402840
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals.
    Feizabadi MM; Fathollahzadeh B; Taherikalani M; Rasoolinejad M; Sadeghifard N; Aligholi M; Soroush S; Mohammadi-Yegane S
    Jpn J Infect Dis; 2008 Jul; 61(4):274-8. PubMed ID: 18653968
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.
    Saballs M; Pujol M; Tubau F; Peña C; Montero A; Domínguez MA; Gudiol F; Ariza J
    J Antimicrob Chemother; 2006 Sep; 58(3):697-700. PubMed ID: 16895941
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Widespread occurrence of aminoglycoside resistance due to ArmA methylase in imipenem-resistant Acinetobacter baumannii isolates in China.
    Yu YS; Zhou H; Yang Q; Chen YG; Li LJ
    J Antimicrob Chemother; 2007 Aug; 60(2):454-5. PubMed ID: 17561497
    [No Abstract]   [Full Text] [Related]  

  • 60. Acinetobacter baumannii: an emerging multidrug-resistant pathogen in critical care.
    Montefour K; Frieden J; Hurst S; Helmich C; Headley D; Martin M; Boyle DA
    Crit Care Nurse; 2008 Feb; 28(1):15-25; quiz 26. PubMed ID: 18238934
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.